XML 42 R13.htm IDEA: XBRL DOCUMENT
v3.20.4

Interests in entities | 12 Months Ended
--- | ---
Dec. 31, 2020
Interests in entities [Abstract] |
Interests in entities [Text Block] | ### 6Interests in entities In this section we discuss the nature of the company’s interests in its consolidated entities and associates, and the effects of those interests on the company’s financial position and financial performance. #### Group companies Below is a list of material subsidiaries as per December 31, 2020 representing greater than 5% of either the consolidated group Sales, Income from operations or Income from continuing operations (before any intra-group eliminations) of Group legal entities. All of the entities are fully consolidated in the group accounts of the company. Philips Group Interests in group companies in alphabetical order by country 2020
Legal entity name | Principal country of business
Philips (China) Investment Company, Ltd. | China
Philips GmbH | Germany
Philips Medizin Systeme Böblingen GmbH | Germany
Philips Japan, Ltd. | Japan
Philips Consumer Lifestyle B.V. | Netherlands
ATL International LLC | United States
Philips Oral Healthcare LLC | United States
Philips North America LLC | United States
Philips RS North America LLC | United States
Philips USA Export Corporation | United States
#### Information related to non-controlling interests As of December 31, 2020, six consolidated subsidiaries are not wholly owned by Philips (December 31, 2019: six). In 2020, Sales to third parties and Net income for these subsidiaries in aggregate are EUR 468 million (December 31, 2019: EUR 581 million) and EUR 6 million (December 31, 2019: EUR 9 million) respectively. #### Investments in associates Philips has investments in a number of associates. None of them are regarded as individually material. During 2020, Philips purchased 6 investments in associates, which involved an aggregate amount of EUR 37 million. #### Involvement with unconsolidated structured entities Philips founded three Philips Medical Capital (PMC) entities, in the United States, France and Germany, in which Philips holds a minority interest. Philips Medical Capital, LLC in the United States is the most significant entity. PMC entities provide healthcare equipment financing and leasing services to Philips customers for diagnostic imaging equipment, patient monitoring equipment, and clinical IT systems. The company concluded that it does not control, and therefore should not consolidate the PMC entities. In the United States, PMC operates as a subsidiary of De Lage Landen Financial Services, Inc. The same structure and treatment is applied to the PMC entities in the other countries, with other majority shareholders. Operating agreements are in place for all PMC entities, whereby acceptance of sales and financing transactions resides with the respective majority shareholder. After acceptance of a transaction by PMC, Philips transfers control and does not retain any obligations towards PMC or its customers, from the sales contracts. At December 31, 2020, Philips’ shareholding in Philips Medical Capital, LLC had a carrying value of EUR 26 million (December 31, 2019: EUR 25 million). The company does not have any material exposures to losses from interests in unconsolidated structured entities other than the invested amounts.

X
- References No definition available. + Details
Name: | phg_InterestsInEntitiesAbstract
Namespace Prefix: | phg_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | phg_InterestsInEntitiesTextBlock
Namespace Prefix: | phg_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration